AVAL Grupo Aval revenue surges 13 YoY to 174T in Q2 yet shares decline 154 on profit concerns Is Aclarion ACON stock suitable for your portfolio 326 20260429 PMTB PennyMac quarterly preferred share earnings metrics not yet released as regulatory filings undergo final review BIOA BioAge Labs posts narrower Q4 2025 loss than expected shares fall 11 percent today AUR Aurora Q4 2025 EPS exceeds consensus forecasts shares post small gains during regular trading Lexaria Bioscience LEXX retreats 5 despite EPS beating estimates by 38 with 52 revenue growth V Visa notches 48 percent Q1 2026 EPS beat yet shares fall 15 percent in todays trading session What AmFin Group AFG disclosed about cost pressures Q1 2026 Below Expectations